The Oncology Institute Inc (TOI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -60,606 | -53,098 | -36,594 | -19,585 | -64,663 |
| Depreciation Amortization | 15,324 | 12,487 | 9,592 | 6,658 | 12,092 |
| Income taxes - deferred | -32 | -32 | -32 | N/A | N/A |
| Accounts receivable | -12,308 | -12,949 | -8,969 | -985 | -5,975 |
| Accounts payable and accrued liabilities | 19,638 | 11,929 | 11,490 | 5,057 | 9,215 |
| Other Working Capital | 1,325 | -6,328 | -156 | 3,129 | 18,059 |
| Other Operating Activity | 12,072 | 20,171 | 9,479 | 738 | 4,734 |
| Operating Cash Flow | $-24,587 | $-27,820 | $-15,190 | $-4,988 | $-26,538 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,200 | -2,140 | -1,536 | -328 | -3,789 |
| Sale Of Investment | N/A | 0 | 0 | 0 | 50,000 |
| Other Investing Activity | 126 | 126 | 126 | 126 | 0 |
| Investing Cash Flow | $-3,074 | $-2,014 | $-1,410 | $-202 | $46,211 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -20,037 | -20,028 | -20,020 | -20,010 | -39 |
| Common Stock Issued | 32,635 | 28,542 | 17,699 | 15,496 | 75 |
| Other Financing Activity | -1,041 | -691 | -456 | -226 | -3,528 |
| Financing Cash Flow | $11,557 | $7,823 | $-2,777 | $-4,740 | $-3,492 |
| Beginning Cash Position | 49,669 | 49,669 | 49,669 | 49,669 | 33,488 |
| End Cash Position | 33,565 | 27,658 | 30,292 | 39,739 | 49,669 |
| Net Cash Flow | $-16,104 | $-22,011 | $-19,377 | $-9,930 | $16,181 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,587 | -27,820 | -15,190 | -4,988 | -26,538 |
| Capital Expenditure | -3,200 | -2,140 | -1,536 | -328 | -3,789 |
| Free Cash Flow | -27,787 | -29,960 | -16,726 | -5,316 | -30,327 |